Tizanidine Tablet
Product Images NDC 72162-1642

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 72162-1642). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tizanidine-1 (Tizanidine 1)

Tizanidine-1 (Tizanidine 1)
Chemical structure of Tizanidine hydrochloride is depicted, showing its molecular framework including rings with chlorine (Cl), nitrogen (N), sulfur (S), and hydrogen chloride (HCl) groups.*
FDA Label Image

Tizanidine-2 (Tizanidine 2)

Tizanidine-2 (Tizanidine 2)
A line graph showing plasma concentration of 4 mg Tizanidine tablets and capsules over time in hours after dosing. The graph compares Tizanidine tablets and capsules taken with and without food, with plasma concentration (ng/ml) on the vertical axis and hours from dosing on the horizontal axis, detailing their pharmacokinetic profiles up to 24 hours.*
FDA Label Image

Tizanidine-3 (Tizanidine 3)

Tizanidine-3 (Tizanidine 3)
A line graph depicting improvement in Ashworth Score over time (hours post-dose) comparing 16 mg tizanidine, 8 mg tizanidine, and placebo groups. The vertical axis shows the improvement level, and error bars represent variability in the data. The horizontal axis ranges from 0 to 6 hours post-dose.*
FDA Label Image

Tizanidine-4 (Tizanidine 4)

Tizanidine-4 (Tizanidine 4)
A line graph depicting improvement in Ashworth Score over study periods for Tizanidine (mean dose 28.8 mg) compared to placebo. Data points show scores at end of titration (study week 3), end of maintenance (study week 7), and study endpoint (last observation carried forward). Error bars indicate variability at each time point.*
FDA Label Image

Label (Lbl721621642)

Label (Lbl721621642)
Label of Tizanidine Tablets, USP 4 mg oral tablets. The label shows the quantity of 1000 tablets, with Bryant Ranch Prepack as relabeler and ALKALOIDA Chemical Company Zrt. as manufacturer. Storage and handling instructions are also visible, including temperature conditions and child-resistant container requirements.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.